We tried to choose a Medicare Part D plan. We were stymied – STAT
We assumed that choosing a Medicare Part D plan would be a straightforward and easily accomplished chore. We couldn’t have been more wrong.
Related Articles
Janet Woodcock, former FDA official, joins board of patient group focused on ‘rediscovering’ old drugs
A doctor inspired by his own fight against a rare malignancy to scour thousands of existing drugs to see if they can cure other diseases…
Wealthy nations might be reaching a life expectancy limit, study suggests — at least for now
Life expectancy gains have substantially slowed in wealthier nations, which appear to be nearing a limit to improvements
Harris seeks to tie expanded Medicare drug price negotiation to home care policy
On “The View,” Kamala Harris announced a plan to fund home care under Medicare by cutting into the pharmaceutical industry’s profits.
U.S. Supreme Court asks solicitor general for views on controversial Oklahoma law for regulating PBMs
The U.S. Supreme Court has asked the solicitor general to weigh in on an Oklahoma law that seeks to regulate the retail networks created by…
Morning Rounds: Physics Nobel, Hurricane Helene, and “Make America Healthy Again”
Today’s health news includes the winner of the Nobel Prize in physics, Hurricane Helene causing IV fluid shortages, and HIV in breast milk.
States sue TikTok, claiming its platform harms the mental health of children
More than a dozen states and the District of Columbia filed lawsuits against TikTok, alleging the popular short-form video app is harming youth mental health.
Compounding group sues FDA for removing Lilly’s obesity drug from its shortages list
A trade group representing compounding pharmacies sued the FDA for a “reckless and arbitrary” decision to remove Eli Lilly’s tirzepatide from an official shortages list.
Biotech veteran John Maraganore raises $135 million for his ‘next-generation RNAi’ startup
.@JMaraganore is launching a new startup that he hopes can expand upon his previous company’s success.
Q&A: Why the NIH is spending $30 million to counter ableism in health care
A new NIH program will allocate the funding to 10 groups over five years to examine the impact of ableism on health outcomes.
2024 Nobel Prize winners: Physics award goes to Hopfield, Hinton for machine learning discoveries
Two pioneers behind machine learning — a technology that is already transforming society and that carries profound ethical questions — won the Nobel Prize in…